Oral delivery of antibodies. Future pharmacokinetic trends

Clinical Pharmacokinetics

Volumn 32, Issue 4, 1997, Pages 313-323

  Reilly, Raymond M ^a   Domingo, Rommel ^a   Sandhu, Jasbir ^b  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTINEOPLASTIC AGENT; CARBOXYPEPTIDASE; CHYMOTRYPSIN; ELASTASE; IMMUNOGLOBULIN; IMMUNOGLOBULIN F(AB) FRAGMENT; IMMUNOGLOBULIN FC FRAGMENT; LIPOSOME; PEPSIN A; PEPTIDE; PROTEIN; TRYPSIN;

BONE MARROW TRANSPLANTATION; CANCER DIAGNOSIS; CANCER THERAPY; DRUG DELIVERY SYSTEM; DRUG STABILITY; DRUG TARGETING; ESCHERICHIA COLI; GASTROINTESTINAL INFECTION; GASTROINTESTINAL TRACT; GENETIC ENGINEERING; IMMUNE DEFICIENCY; IMMUNOTHERAPY; INTRAVENOUS DRUG ADMINISTRATION; MUCOSA INFLAMMATION; ORAL DRUG ADMINISTRATION; PHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVIEW; ROTAVIRUS; VIBRIO CHOLERAE;

EID: 0030939883     PISSN: 03125963     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003088-199732040-00004     Document Type: Review

References (53)

1. Reilly RM, Sandhu J, Alvarez-Diez TM, et al. Problems of delivery of monoclonal antibodies: pharmaceutical and pharmacokinetic solutions. Clin Pharmacokinet 1995; 28: 126-42
2. Haber E. In vivo diagnostic and therapeutic uses of monoclonal antibodies in cardiology. Annu Rev Med 1986; 37: 249-61
3. Steplewski Z. Advances and outlooks for immunotherapy of cancer. Hybridoma 1993; 12: 493-500
4. Guarino A, Canani RB, Russo S, et al. Oral immunoglobulins for treatment of acute rotaviral gastroenteritis. Pediatrics 1994; 93 (1): 12-6
5. Morelli D, Menard S, Colnaghi MI, et al. Oral administration of anti-doxorubicin monoclonal antibody prevents chemotherapy-induced gastrointestinal toxicity in mice. Cancer Res 1996; 56: 2082-5
6. Van de Graaff KM. Anatomy and physiology of the gastrointestinal tract. Pediatr Infect Dis J 1986; 5: S11-6
7. Britton JR, Koldovsky O. The development of luminal protein digestion: implications for biologically-active dietary polypeptides. J Pediatr Gastroenterol Nutr 1989; 9: 114-61
8. Hatta H, Tsuda K, Akachi S, et al. Oral passive immunization effect of anti-human rotavirus IgY and its behaviour against proteolytic enzymes. Biosci Biotechnol Biochem 1993; 57 (7): 1077-81
9. Neu J. Functional development of the fetal gastrointestinal tract. Semin Perinatol 1989; 13: 224-35
10. Madsen JL. Gastrointestinal transit measurements: a scintigraphic method. Dan Med Bull 1994; 41: 398-411
11. Ritschel WA. Targeting in the gastrointestinal tract: new approaches. Methods Find Exp Clin Pharmacol 1991; 13: 313-36
12. Fallingborg J, Christensen LA, Ingeman-Nielsen M, et al. Measurement of gastrointestinal pH and regional transit times in normal children. J Pediatr Gastroenterol Nutr 1990; 11: 211-4
13. Alpers DH, Johnson LR, editors. Digestion and absorption of carbohydrates and proteins. In: Physiology of the gastrointestinal tract. New York: Raven Press, 1987: 1469-87
14. Gardner MG. Intestinal assimilation of intact peptides and proteins from the diet: a neglected field? Biol Rev 1984; 59: 289-331
15. Gardner MLG. Passage of intact peptides across the intestine. Adv Biosci 1987; 65: 99-106
16. Saffran M. Oral administration of peptides. Endocrinol Exp 1982; 16: 327-33
17. Warshaw AL, Walker WA, Isselbacher KJ. Protein uptake by the intestine: evidence for absorption of intact macromolecules. Gastroenterology 1974; 66: 987-92
18. Walker WA, Isselbacher KJ. Uptake and transport of macromolecules by the intestine: possible role in clinical disorders. Gastroenterology 1967; 67: 531-50
19. Hemmings WA, Williams EW. Transport of large breakdown products of dietary protein through the gut wall. Gut 1978; 19: 715-23
20. Iyengar L, Selvaraj RJ. Intestinal absorption of immunoglobulins by newborn infants. Arch Dis Child 1972; 47: 411-7
21. Petschow BW, Talbott RD. Reduction in virus-neutralizing activity of a bovine colostrum immunoglobulin concentrate by gastric acid and digestive enzymes. J Pediatr Gastroenterol Nutr 1994; 19 (2): 228-35
22. de Rham O, Isliker H. Proteolysis of bovine immunoglobulins. Int Arch Allergy Appl Immunol 1977; 55 (1-6): 61-9
23. Hilpert H, Brussow H, Mietens C, et al. Use of bovine milk concentrate containing antibody to rotavirus to treat rotavirus gastroenteritis in infants. J Infect Dis 1987; 156 (1): 158-66
24. Hatta H, Tsuda K, Sigemitu A, et al. Productivity and some properties of egg yolk antibody (IgY) against human rotavirus compared with rabbit IgG. Biosci Biotechnol Biochem 1993; 57 (3): 450-4
25. Shimizu M, Fitzsimmons RC, Nakai S. Anti-E. coli immunoglobulin Y isolated from egg yolk of immunized chickens as a potential food ingredient. J Food Sci 1988; 53 (5): 1360-6
26. Blum PM, Phelps DM, Ank BJ, et al. Survival of oral human immune serum immunoglobulin in the gastrointestinal tract of low birth weight infants. Pediatric Res 1981; 15 (9): 1256-60
27. Shimizu M, Nagashima H, Sano K, et al. Molecular stability of chicken and rabbit immunoglobulin G. Biosci Biotechnol Biochem 1992; 56 (2): 270-4
28. Eibl MM, Wolf HM, Furnkranz H, et al. Prevention of necrotizing enterocolitis in low-birth weight infants by IgA-IgG feeding. N Engl J Med 1988; 319 (1): 1-7
29. Zinkernagel RM. The digestion of colostral bovine immunoglobulins in infants. Experientia 1972; 28: 741
30. Losonsky G, Johnson JP, Winkelstein JA, et al. Oral administration of human serum immunoglobulin in immunodeficient patients with viral gastroenteritis: a pharmacokinetic and functional analysis. J Clin Invest 1985; 76 (6): 2362-7
31. Roos N, Mahe S, Benamouzig R, et al. 15N-labeled immunoglobulins from bovine colostrum are partially resistant to digestion in human intestine. J Nutr 1995; 125 (5): 1238-44
32. Martin MG, Wu SV, Ohning G, et al. Parenterally or enterally administered anti-somatostatin antibody induces increased gastrin in suckling rats. Am J Physiol 1994; 266 (3 Pt 1): G417-24
33. Shimizu M, Miwa Y, Hashimoto K, et al. Encapsulation of chicken egg yolk immunoglobulin G (IgY) by liposomes. Biosci Biotechnol Biochem 1993; 57 (9): 1445-9
34. Shimizu M, Nakane Y. Encapsulation of biologically active proteins in a multiple emulsion. Biosci Biotechnol Biochem 1995; 59 (3): 492-6
35. Cornes J. Number, size, and distribution of Peyer's Patches in the human small intestine: II. The effect of aging on Peyer's Patches. Gut 1965; 6: 230
36. Heizer WD, Laster L. Peptide hydrolase activities of the mucosa of human small intestine. J Clin Invest 1969; 48: 210-28
37. Sandhu JS. Protein engineering of antibodies. Crit Rev Biotechnol 1992; 12: 437-62
38. Hozumi N, Sandhu JS. Recombinant antibody technology: its advent and advances. Cancer Invest 1993; 11: 714-23
39. McCafferty J, Griffiths AD, Winter G, et al. Phage antibodies: filamentous phage displaying antibody variable domains. Nature 1990; 348: 552-4
40. Sandhu JS. A simple and rapid method of humanisation of antibodies. Gene 1994; 150: 409-10
41. Hammarstrom L, Gardulf A, Hammarstrom V, et al. Systemic and topical immunoglobulin treatment in immunocompromised patients. Immunol Rev 1994; 139: 43-70
42. Hilpert H, Gerber H, Amster H, et al. Bovine milk immunoglobulins (Ig), their possible utilization in industrially prepared infants' milk formula. In: Hambracus L, Hanson LA, McFarlane H, editors. Proceedings of a symposium of the Swedish Medical Research Council. Stockholm: Almqvist and Wiksell International, 1977: 182-96
43. Mietens A, Keinhorst H, Hilpert H, et al. Treatment of infantile E. coli gastroenteritis with specific bovine anti-E. coli milk immunoglobulins. Eur J Pediatr 1979; 132: 239
44. Nord J, Ma P, DiJohn D, et al. Treatment with bovine hyperimmune colostrum of cryptosporidial diarrhea in AIDS patients. AIDS 1990; 4: 581-4
45. Ungar BLP, Ward DJ, Fayer R, et al. Cessation of cryptosporidium-associated diarrhea in an acquired immunodeficiency syndrome patient after treatment with hyperimmune bovine colostrum. Gastroenterology 1990; 98: 486-9
46. Copelan EA, Avalos BR, Kapoor N, et al. Alternate applications of immunoglobulin following bone marrow transplantation. Semin Hematol 1992; 29 (3 Suppl. 2): 96-9
47. Copelan EA, Bechtel TP, Klein JP, et al. Controlled trial of orally administered immunoglobulin following bone marrow transplantation. Bone Marrow Transplant 1994; 13 (1): 87-91
48. Hollwarth ME, Schuher P, Pfleger A, et al. Necrotising enterocolitis: results of surgery. Pediatr Surg Int 1992; 7: 421-7
49. Kanto WP, Wilson R, Ricketts RR. Management and outcome of NEC. Clin Pediatr 1985; 24: 79-82
50. Lucas A, Cole TJ. Breast milk and neonatal necrotising enterocolitis. Lancet 1990; 336: 1519-23
51. Wolf HM, Eibl MM. The anti-inflammatory effect of an oral immunoglobulin (IgA-IgG) preparation and its possible relevance for the prevention of necrotizing enterocolitis. Acta Pediatr 1994; 396 Suppl.: 37-40
52. Chabner BA, Myers CE. Antitumour antibiotics. In: DeVita VT, Hellman S, Rosenberg SA, editors. Cancer principles and practice of oncology. Philadelphia: Lippincott, 1993; 374-84
53. Bernbisel-Broadbent J, Yolken RH, Sampson HA. Allergenicity of orally administered immunoglobulin preparation in food-allergic children. Pediatrics 1991; 87: 208-14